Navigation Links
Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer
Date:3/8/2012

ubmit for regulatory approval in the United States and around the world beginning in the second half of 2012.

The recommendation to unblind a clinical study at an interim analysis is made by an Independent Data Monitoring Committee based on predetermined criteria, such as meeting certain efficacy endpoints and the risk/benefit profile, as well as ethical considerations.  In cases where there is compelling evidence of clinical benefit, the IDMC may also recommend that patients in the placebo arm of the study be crossed over to the active arm.

About ZYTIGA
"Since its first approval in the U.S. in 2011, ZYTIGA has been approved in 39 additional countries, many thousands of men have received treatment with it, and it is quickly becoming one of the cornerstones of our oncology offerings," said Hait.

ZYTIGA in combination with prednisone was approved by the U.S. Food and Drug Administration (FDA) in April 2011 for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.  The Phase 3 study for this initial ZYTIGA indication was also unblinded at the interim point, in August 2010, based on a statistically significant improvement in overall survival and an acceptable safety profile.  A subsequent analysis with more mature data confirmed the survival benefit and safety profile.

Indication
ZYTIGA® (abiraterone acetate) in combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC) who have received prior chemotherapy containing docetaxel.

Important Safety Information

Contraindications - ZYTIGA® (abiraterone acetate) may cause fetal harm (Pregnancy Category X) and is contraindicated in women who are or may become pregnant.

Hypertension, Hypokalemia and Fluid Retention Due to Mineralocorticoid Excess - Use with ca
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... TODAY, AEGATE, the leader in ... the appointment of Peter Fox as Chief ... and Partner Officer. Peter has served as ... acquisition by Oracle in 2011. Prior to ... and subsequently Convergys, a world renowned billing ...
(Date:12/19/2014)... You,re visiting the dentist for what you ... or she says you need a root canal. Though ... have several questions and feel apprehensive about your upcoming ... nothing to worry about. The Pennsylvania Dental Association (PDA) ... anxiety the public may have surrounding this common procedure ...
(Date:12/19/2014)... Fla. , Dec. 19, 2014 Breckenridge ... a multi-product agreement with MSN Laboratories Pvt. Ltd. ( ... MSN expect to commercialize several new ANDAs.  Under the ... supply the products exclusively to Breckenridge for the U.S. ... under its label.  Breckenridge and MSN have agreed to ...
Breaking Medicine Technology:Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Root Canals Have Become More Routine 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2
... Surgical Information Systems ("SIS"), a leader in ... Health System has extended its enterprise agreement with ... solution. The implementation will start at North Shore University ... Health Systems hospitals. (Logo:   http://photos.prnewswire.com/prnh/20080722/SISLOGO ...
... 2011 Mitsubishi Chemical Medience Corporation announced today ... has granted 510(k) premarketing notification clearance to the ... the way for its sale in the United ... with the PATHFAST analysis system, a unique, self-contained, ...
Cached Medicine Technology:North Shore-LIJ Health System Selects SIS Anesthesia 2North Shore-LIJ Health System Selects SIS Anesthesia 3North Shore-LIJ Health System Selects SIS Anesthesia 4Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S. 2Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S. 3
(Date:12/22/2014)... 22, 2014 As part of ... care service in San Diego and surrounding ... its senior care team with ongoing online training ... Care is provided by Caregiverlist®. Caregiverlist® is ... with the most reliable eldercare options, highest quality ...
(Date:12/22/2014)... December 22, 2014 Sagacious Consultants, the ... a subscription option to their ad hoc report writing ... services. Customers can sign up for an annual subscription ... each month at a deeply discounted hourly rate. ... each has a progressively discounted rate. Subscription hours are ...
(Date:12/22/2014)... NC (PRWEB) December 22, 2014 ... the current Ebola virus epidemic are receiving ... U.S. government agencies, nongovernmental organizations (NGOs) and ... remains ongoing, healthcare workers, emergency responders, patients ... technologies such as the CmTP MediDefense ...
(Date:12/22/2014)... The Bob Woodruff Foundation will ... more than $5 million in programs and organizations ... families. , This includes $1.3 million in grants ... with: veteran entrepreneurship; community impact; vocational training; transportation; ... injured veterans. , “The needs of those injured ...
(Date:12/22/2014)... Give a loved one the greatest gift of ... vitality. , For a limited time, HealthiPlus ( https://healthiplus.com/christmas-gift-packages/ ... special Holiday Wellness gift packages at drastically reduced prices ... contains cutting-edge, proven nutritional support for joints, mental functioning ... we age. , Joint Health Plus contains ...
Breaking Medicine News(10 mins):Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2
... Suicidal teens are not likely to get the ... team of researchers at Seattle Children,s Research Institute, the ... The study, "Adolescents With Suicidal Ideation: Health Care Use ... . The researchers found that only 13 ...
... (September 2011) Research conducted by Boston College neuroscientist Sean ... finds evidence of a new way of considering how the ... paper published in the latest issue of Nature Neuroscience ... magnetic resonance image (fMRI) to help them identify how the ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... of lymph nodes after colon cancer surgery does not seem ... Researchers from the U.S. National Cancer Institute analyzed data ... and End Results (SEER) cancer registry. The investigators found ...
... Medicine have found that thyroid-stimulating hormone (TSH), a hormone ... function in the thyroid gland, can promote bone growth ... that TSH, or drugs that mimic its affect on ... osteoporosis and other conditions involving bone loss, such as ...
... (HealthDay News) --,Statins, a widely prescribed class of drugs used ... of brain bleeds in people who,ve had strokes, new research ... an ischemic stroke, caused by blocked blood flow to the ... two previous reviews raised concerns that statins might also raise ...
... previously unrelated imaging tools into one new device, a ... the University of Southern California has proposed a new ... through minimally invasive surgery. The new technique may be ... the ovaries. Ovarian cancer has a low ...
Cached Medicine News:Health News:Study finds over 70 percent of suicidal teens don't get the mental health services they need 2Health News:Study finds over 70 percent of suicidal teens don't get the mental health services they need 3Health News:Researchers utilize neuroimaging to show how brain uses objects to recognize scenes 2Health News:Screening Lots of Lymph Nodes Little Help for Colon Cancer Patients 2Health News:Screening Lots of Lymph Nodes Little Help for Colon Cancer Patients 3Health News:Pituitary hormone TSH found to directly influence bone growth 2Health News:Statins Don't Raise Risk of Brain Bleeds After Stroke: Study 2
... VenaCure Laser Vein Treatment. It is estimated ... worldwide have varicose veins. In the United States, ... of 60 suffer from painful and unsightly venous ... the capabilities of vascular therapy for the treatment ...
ELVeS is a new minimally-invasive laser treatment for patients with superficial vein reflux of the greater saphenous vein. The ELVeS laser treatment offers your patients an effective out-patient alt...
... technology provides practitioners with the ability to treat ... permanent hair reduction on all skin types and ... the practitioner to instantly switch to a 3, ... a simple twist of the handpiece dial while ...
... people are diagnosed with varicose veins every ... never seek treament and are apprehensive of ... them an effective alternative to conventional therapies., ... hook phlebectomy), is considered a laborious procedure ...
Medicine Products: